Poor control of diabetes in a large sample of patients

Patients with diabetes mellitus are less likely to develop vascular complications (such as retinopathy, nephropathy and coronary artery disease) if their blood sugar levels are tightly controlled. Physicians use a simple blood test — glycosylate hemoglobin (HBA 1c ) — to measure control and guide therapy.

In this study, Woodward and colleagues identified over 63 000 patients in eastern Ontario with diabetes, and examined their control over their blood sugar and how often it was evaluated. During the one-year period of the study, only 58% of the patients had the test done; and of those who were tested, fewer than half were in good control of their blood sugar levels.

Testing was most common among patients 50 to 70 years old, and was least common among young adults 20 to 34 years of age. The finding that younger patients were tested least often and had poorer test results is particularly worrisome.

p. 327 Utilization and outcomes of HbA1c testing: a population-based study — J. Hux

Media Contact

Dr. Jan Hux EurekAlert!

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Making diamonds at ambient pressure

Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…

Eruption of mega-magnetic star lights up nearby galaxy

Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…

Solving the riddle of the sphingolipids in coronary artery disease

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…

Partners & Sponsors